VIDEO: What to expect from Thermo Fisher Scientific at the 2025 ISPE Annual Meeting

In this Conference Sneak Peek, Susan Oliveria (Vice President and Global Head of Epidemiology and Scientific Affairs, PPD Observational Studies, Thermo Fisher Scientific) shares what attendees can expect from the company at the 2025 International Society for Pharmacoepidemiology (ISPE) Annual Meeting.

You can view the entire video or view a specific question by entering ‘Fullscreen’ or navigate via the ‘Visual Table of Contents’.

Questions:

• 00:00: How is the pharmacoepidemiology research landscape evolving, and how are the associated research methods becoming increasingly valuable in shaping healthcare decisions?
• 01:46: Looking ahead to the 2025 ISPE Annual Meeting, what can attendees expect from Thermo Fisher Scientific, and how does the research you are presenting complement your broader presence at the event?
• 02:44: What’s next for Thermo Fisher Scientific in advancing pharmacoepidemiology research and supporting innovation in this space?

Dr Susan A. Oliveria, ScD, MPH, FISPE
Vice President and Global Head of Epidemiology and Scientific Affairs 
PPD Observational Studies
Thermo Fisher Scientific

Dr Oliveria’s career as a pharmacoepidemiologist spans more than 25 years in academia, industry, and non-profit settings. She is trained as a pharmacoepidemiologist, having received her Doctor of Science from the Harvard School of Public Health. In her current role she leads the scientific teams and activities focused on generating real-world evidence and peri- and post-approval studies to support the value of drugs and devices throughout development and lifecycle management. Before joining Thermo Fisher Scientific, she served as Chief Scientific Officer at Genesis Research, a RWE consulting company. In a prior role as Practice Leader, Epidemiology & Drug Safety, Real World Solutions at IQVIA, she was responsible for leading and accelerating the growth of a global practice that leveraged real-world evidence in regulated use cases and innovative study designs. Previously, she founded Epidemiology Research Group, was a co-founder of EpiSource, and held several academic positions and appointments at Memorial Sloan-Kettering Cancer Center, Cornell University Medical School, Department of Public Health, and New York Medical College. She is a member of medical and scientific societies, including the International Society for Pharmacoepidemiology's (ISPE's) RWE Collaborative SIG and the Duke-Margolis RWE Collaborative. She is a GetReal Institute Board Member as well as the ISPE liaison, and the ISPE representative for the Duke-Margolis Workgroup: Regulatory Acceptability of RWD/E and Patient-Level Data. Her prior leadership roles for ISPE have included: Industry Board Member, Industry Council Chair, Development Committee Chair, and Finance Committee member.

Sponsorship for this Conference Sneak Peek was provided by Thermo Fisher Scientific.